Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Total Debt/Equity

    Back to All Ratios
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.05--0.020.16

What is the latest Total Debt/Equity ratio of WINDLAS BIOTECH ?

The latest Total Debt/Equity ratio of WINDLAS BIOTECH is 0.05 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.05
Mar2024-
Mar2023-
Mar20220.02
Mar20210.16

How is Total Debt/Equity of WINDLAS BIOTECH Trending?

Years Total Debt/Equity % Change
Mar2025 0.05
0
Mar2024 0
0
Mar2023 0
-100.00
Mar2022 0.02
-87.50
Mar2021 0.16 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Total Debt/Equity ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,670.8 Cr -5.4% 4.8% -17.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-5.4%

4.8%

-17.6%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses